This increased MC burden in systemic mastocytosis (SM) is most often associated with the presence of an activating mutation in the catalytic domain of KIT, the receptor for stem cell factor, that causes ligand-independent activation of KIT and downstream signaling, especially within the MC compartment (20–22). Here, KIT is linked to systemic mastocytosis.